SecBot SecBot
Institutional Cluster

CPRX

CATALYST PHARMACEUTICALS, INC.
MIXED
Impact 5/10
Horizonweeks Processed2mo ago
Institutional cluster: 23 buyers, 22 sellers (mixed)
Actionable Insight ◆ Mixed

The mixed cluster with heavy passive accumulation but active-manager distribution suggests no clear catalyst consensus. Monitor for insider buying or a catalyst (e.g., pipeline update, FDA decision) to break the stalemate. The Soros new stake adds optionality but is offset by the near-exit of Susquehanna and Jane Street.

DirectionMixed
Confidencemedium
Horizonweeks

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CPRX saw a mixed institutional cluster in Q2 2026: 23 buyers added $226.9M in new positions (led by JPMorgan, American Century, and a new Soros stake), while 22 sellers reduced holdings by $89.4M (led by BofA, Susquehanna, and Jane Street). The net buying of ~$137.5M is notable, but the heavy selling by quant and asset-manager funds creates a split signal with no insider corroboration, suggesting the stock is in a tug-of-war between accumulating passive/quant funds and distributing active managers.

Key Financial Metrics

Direction
mixed
Buy Value
$409.6M
Sell Value
$89.4M
Net Flow
$137.5M

Institutional Positions

Net institutional flow: $137.5M

▲ Buyers (23)

InstitutionActionChangePosition ValueValue Δ
JPMorganDOUBLED+579%$99.9M$88.8M
American Century CompaniesADD+34.2%$174.6M$72.1M
Soros Fund ManagementNEWNot reported$10.8M$10.8M
UBSADD+47.4%$45.7M$21.3M
Millennium ManagementADD+39.3%$33.6M$14.6M

▼ Sellers (22)

InstitutionActionChangePrev ValueValue Δ
BofATRIM-56.8%$75.2M-$34.0M
Susquehanna International GroupNEAR_EXIT-95.1%$21.1M-$19.8M
Jane Street GroupNEAR_EXIT-96.6%$13.5M-$12.9M
Citadel AdvisorsNEAR_EXIT-85.3%$14.4M-$11.7M
Point72 Asset ManagementTRIM-58.5%$10.5M-$5.0M

Key Facts

  • 23 institutional buyers added $226.9M in new CPRX positions in Q2 2026
  • 22 institutional sellers reduced holdings by $89.4M, net buying of ~$137.5M
  • JPMorgan doubled its stake (+579% shares) to $99.9M, the largest buyer
  • Soros Fund Management initiated a new $10.8M position
  • BofA trimmed 56.8% of its stake, selling $34.0M, the largest seller
  • No open-market insider buying in the window, institutions-only signal
  • Analyst consensus is 0% bullish (0 Buy, 6 Hold, 3 Sell/Strong Sell)

Financial Impact

Net institutional buying of ~$137.5M in Q2 2026, with 23 buyers adding $226.9M and 22 sellers reducing $89.4M

institutional ownershipfloat turnover

Risk Factors

  • No insider buying corroborates the institutional signal, weakening conviction
  • Heavy selling by quant funds (Citadel, Point72) and asset managers (Susquehanna, Jane Street) suggests thesis fatigue
  • Analyst consensus is bearish with 0% bullish ratings

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CPRX-2026-Q2

Track record

16 reports on CPRX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +25.72% at T+60 after the Feb 25, 2026 report. 6 of 9 went positive at some point.

Filters
  1. Nov 4, 202612d ago Institutional Cluster Bearish 4/10 No price data
  2. Aug 22, 202612w ago Institutional Cluster Mixed 5/10 Viewing No price data
  3. Jul 24, 202616w ago 15-12G Bearish 9/10 Entry $31.49 No price data
  4. Jul 17, 202617w ago EFFECT Bearish 5/10 Entry $31.49 No price data
  5. Jul 15, 202617w ago 25-NSE Bearish 9/10 Entry $31.49 No price data
  6. Jul 8, 202618w ago 8-K Bullish 6/10 Entry $31.47 No price data
  7. Jun 30, 202619w ago DEFA14A Neutral 3/10 Entry $31.44 No price data
  8. Jun 30, 202619w ago 8-K Neutral 4/10 Entry $31.44 No price data
  9. May 28, 202624w ago PREM14A Bullish 8/10 Entry $31.23 to $31.46 ▲ +0.74% +2.53% vs SPY
  10. May 12, 202626w ago DEFA14A Neutral 3/10 Entry $31.14 to $31.34 ▲ +0.64% +2.37% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 22, 2026